Fulgent Genetics

FLGTNasdaq United States Health Care Medical Specialities

Market cap

$526.643 M

$19.14 +3.18%

Close of 7 Aug 2026

Revenue

$322.7M

#2108 by revenue

Earnings

-$60.5M

Loss-making

Shares outstanding

27,515,293

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities — ranked by market cap

All 44 →

#29Lumexa ImagingLMRI$1.11B
#30Castle BiosciencesCSTL$978.5M
#31Fulgent GeneticsFLGT$526.6M
#32TriSalus Life SciencesTLSI$344.5M
#33BiodesixBDSX$248.0M

Where these numbers come from

Share counts and financials for Fulgent Genetics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.